Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Sandra Breuils‐Bonnet et al.|Circulation|2025Cited by 26
Identification of integrin a5b1 inhibition as a potentially disease-modifying approach for the treatment of pulmonary arterial hypertensionMónica S. Montesinos, Min Lü, Sarah‐Eve Lemay et al.|Unknown|2024Cited by 0
Abstract 4143098: Development and characterization of an ex vivo human precision-cut lung slice (hPCLS) system for target validation for pulmonary arterial hypertensionHae Jin Kim, Bryan Goodwin, Muzaffar Akram et al.|Circulation|2024Cited by 0
Abstract 4139371: Treatment of pulmonary arterial hypertension by blocking integrin a5b1, a potential disease-modifying strategyMónica S. Montesinos, Min Lü, Sarah‐Eve Lemay et al.|Circulation|2024Cited by 0